Telecom software provider Amdocs (NASDAQ: DOX) met Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q4 2026), with sales up 3.8% year on year to $1.19 billion. On the other hand, next quarter’s revenue guidance of $975 million was less impressive, coming in 18.7% below analysts’ estimates. Its non-GAAP profit of $1.98 per share was in line with analysts’ consensus estimates.

Is now the time to buy DOX? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Amdocs reported in-line financial results for the third quarter, but the market responded negatively due to concerns about major headwinds, specifically with a large telecommunications customer. Management attributed the quarter’s performance to strong momentum in its core product, aOS (Agentic Operating System for Telco), and highlighted new strategic agreements with major carriers. However, CEO Shimie Hortig acknowledged a cautious outlook, noting, “We are facing a major headwind due to the situation we have with T-Mobile.”

Looking ahead, Amdocs’ guidance reflects the anticipated impact of reduced business with T-Mobile, a legal dispute, and divestitures of non-core operations. Management is focused on growth opportunities in both the telco and insurance sectors, banking on large-scale customer wins and the introduction of agentic technologies. Hortig stated, “Although 2027 will be financially challenging, it will also be a year of strategic transition, setting us for long-term success and growth.”

Key insights from management’s remarks

Management emphasized that the quarter’s results were shaped by new large-scale aOS partnerships and a strategic push into the insurance vertical, while also addressing significant revenue challenges stemming from one major customer.

• aOS traction with global carriers: Amdocs secured multi-year agentic platform deals with AT&T, VEON, Globe, and VodafoneThree, expanding both geographic reach and depth of customer relationships. These agreements are designed to accelerate operational transformation and embed AI-driven workflows for telecom clients.
• Insurance vertical entry: The acquisition of EIS marks Amdocs’ formal entry into the insurance software market. Management believes the insurance sector shares high regulatory complexity with telecom and expects to leverage Amdocs’ aOS technology and transformation expertise to offer differentiated solutions for insurance carriers.
• Portfolio rationalization: The company exited or minimized investment in legacy and non-strategic products, including the sale of its media business (Vubiquity) and a full exit from hardware resale. This streamlining aims to focus organizational resources on agentic and AI-powered offerings.
• Internal transformation: Amdocs rolled out AI-enabled practices across 10,000 employees and 800 hubs, targeting higher productivity and operational agility. Management cited measurable gains from adopting an agentic software development lifecycle (SDLC) and plans to extend these practices beyond engineering.
• T-Mobile exposure and legal dispute: A legal dispute with T-Mobile, a significant customer, has led to a sharp reduction in revenue outlook for the next year. Management characterized this as an isolated incident, stating that other large customer relationships remain stable and are driving growth through new contracts.

Drivers of future performance

Management expects near-term performance to be shaped by the loss of a large customer, combined with the scaling of new strategic initiatives in telco and insurance.

• T-Mobile revenue headwind: The company’s outlook incorporates a conservative assumption of reduced revenue from T-Mobile due to decreased discretionary spending and a legal dispute. This single customer event is expected to drive a year-over-year revenue decline, while management maintains that the remainder of the business is on track for mid-single-digit growth.
• Growth from agentic platform adoption: Management is optimistic about continued momentum from the aOS platform, citing recent wins with AT&T and international carriers as primary drivers of organic growth. These multi-year agreements are expected to ramp up over time, offsetting some of the impact from customer attrition.
• Insurance market expansion: The EIS acquisition is intended to establish a foothold in the insurance vertical, with management planning to integrate agentic solutions for insurance clients. While near-term contributions are expected to be modest, Amdocs views this as a long-term growth engine that leverages its core competencies in regulated, mission-critical software.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be monitoring (1) the ramp-up and revenue realization from recent aOS deals with major carriers, (2) successful integration and early customer traction in the insurance vertical following the EIS acquisition, and (3) resolution or progress in the T-Mobile dispute and its direct impact on revenue and margins. The effectiveness of internal AI-driven transformation initiatives will also be a significant focus.

Amdocs currently trades at $34.50, down from $62.43 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

Our favorite stocks right now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.